$1.15
+0.01 (+0.88%)
Open$1.15
Previous Close$1.14
Day High$1.16
Day Low$1.12
52W High$1.19
52W Low$0.54
Volume—
Avg Volume140.6K
Market Cap13.28M
P/E Ratio—
EPS$-1.18
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+3,774.8% upside
Current
$1.15
$1.15
Target
$44.56
$44.56
$28.75
$44.56 avg
$50.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 47.34M | 41.78M | 1.67M |
| Net Income | -11,960,416 | -9,499,933 | 470.0K |
| Profit Margin | -25.3% | -24.0% | 28.1% |
| EBITDA | -11,264,130 | -9,443,935 | 856.8K |
| Free Cash Flow | — | — | 585.2K |
| Rev Growth | +13.3% | +13.3% | +24.3% |
| Debt/Equity | 0.44 | 0.44 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |